
The FDA’s new CBER Safety Council separates post-market biologics safety review from approvals, raising oversight for cell and gene therapy developers.
Finn Bauer talks about Parteck SRP 80, an excipient for direct compression of matrix-based, sustained-release tablets. Parteck SRP 80 won the Excellence in Excipients Award at the 2016 CPhI Pharma Awards.
Finn Bauer talks about Parteck SRP 80, an excipient for direct compression of matrix-based, sustained-release tablets. Parteck SRP 80 won the Excellence in Excipients Award at the 2016 CPhI Pharma Awards.





